AEON Biopharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,511 | -4,302 | -3,931 | -5,643 |
EBIT | -2,530 | -4,322 | -3,950 | -5,666 |
Net Income | -4,538 | -6,642 | 9,095 | 2,082 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,596 | -2,091 | -7,913 | -621 |
Cash | 5,927 | 8,439 | 10,446 | 13 |
Basic Shares | 11,634 | 11,090 | 3,984 | 555 |
Annual Financials
| Values in thousands | 2024-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -27,727 | -48,361 | -36,878 |
EBIT | -27,824 | -48,429 | -36,881 |
Net Income | 42,005 | -52,556 | -55,637 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -20,292 | -35,890 | -28,603 |
Cash | 13 | 9,746 | 5,128 |
Basic Shares | 575 | 1,928 | 1,753 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.39 |
2025-06-30 | -$0.60 |
2025-03-31 | $2.28 |
2024-12-31 | $3.47 |
